Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFCI ALL Adult Consortium Protocol 06-254
NCT01005758Phase 2Unknown
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jan 2009
- Primary completion
- Jan 2013
- Modality
- Therapeutic Enzymes
01
Overview
A Phase 2 trial of pegaspargase in acute lymphoblastic leukemia (ALL), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Status: unknown.
02
Drugs
pegaspargase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01005758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005758.